0001062993-24-001252.txt : 20240124
0001062993-24-001252.hdr.sgml : 20240124
20240124172110
ACCESSION NUMBER: 0001062993-24-001252
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240122
FILED AS OF DATE: 20240124
DATE AS OF CHANGE: 20240124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mehalik Daniella
CENTRAL INDEX KEY: 0002003597
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13738
FILM NUMBER: 24557711
MAIL ADDRESS:
STREET 1: 100 HALE STREET
CITY: NEWBURYPORT
STATE: MA
ZIP: 01950
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PSYCHEMEDICS CORP
CENTRAL INDEX KEY: 0000806517
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 581701987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 125 NAGOG PARK
CITY: ACTON
STATE: MA
ZIP: 01720
BUSINESS PHONE: 978-206-8220
MAIL ADDRESS:
STREET 1: 125 NAGOG PARK
CITY: ACTON
STATE: MA
ZIP: 01720
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2024-01-22
0000806517
PSYCHEMEDICS CORP
PMD
0002003597
Mehalik Daniella
C/O PSYCHEMEDICS CORPORATION
289 GREAT ROAD, SUITE 200
ACTON
MA
01720
0
1
0
0
Vice President - Finance
0
Stock Option (Right to Buy)
3.40
2024-01-22
4
A
0
35000
0
A
2034-01-22
Common Stock, $.005 Par Value
35000
35000
D
Stock Option (Right to Buy)
3.40
2024-01-22
4
A
0
70000
0
A
2034-01-22
Common Stock, $.005 Par Value
70000
70000
D
The option becomes exercisable with respect to 50% of the shares on January 22, 2025 and with respect to the remaining 50% on January 22, 2026.
The option becomes exercisable, if at all, in two 35,000 share increments. The first increment of 35,000 shares becomes exercisable at the time the weighted average daily price of Psychemedics common stock on the Nasdaq Stock Market during any consecutive 60 calendar day period ending on or before January 22, 2027 shall have exceeded $5.50. The second increment of 35,000 shares becomes exercisable at the time the weighted average daily price of Psychemedics common stock on the Nasdaq Stock Market during any consecutive 60 calendar day period ending on or before January 22, 2028 shall have exceeded $6.50.
Patrick J. Kinney, Jr. as attorney-in-fact for Daniella Mehalik
2024-01-24